IBIO INC.      DL -,001
IBIO INC. DL -,001
Share · US4510337086 · IBIO · A3E2GR (XASE)
Overview Financial Indicators
0,86 EUR
3,17 % 0,03 EUR
Frankfurt (XNYS) · Current prices and charts at MoneyPeak
11.06.2025 23:19

Current Prices from IBIO INC. DL -,001

ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
IBIO
USD
11.06.2025 23:19
0,98 USD
0,95 USD
+3,16 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
3,05 % -2,85 % 24,48 % -82,68 % -66,55 % -61,65 % -99,88 %

Firmenprofil zu IBIO INC. DL -,001 Aktie

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with CC-Pharming Ltd. The company is headquartered in Bryan, Texas.

Unternehmensdaten

Name IBIO INC. DL -,001
Firma iBio, Inc.
Symbol IBIO
Website https://www.ibioinc.com
Heimatbörse XASE Frankfurt
WKN A3E2GR
ISIN US4510337086
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Martin B. Brenner D.V.M., Ph.D.
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 0,0 T
Adresse 8800 HSC Parkway, 77807 Bryan
IPO Datum 2008-08-19

Kennungs-Wechsel

Datum Von Zu
06.01.2011 IBPM IBIO

Ticker Symbole

Name Symbol
Frankfurt 0JV0.F
NYSE IBIO

Weitere Aktien

Investoren die IBIO INC. DL -,001 die halten, haben auch folgende Aktien im Depot:
AUB GROUP LTD.
AUB GROUP LTD. Aktie
LB.HESS.THR.CARRARA10K/23
LB.HESS.THR.CARRARA10K/23 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025